Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
2018 was a very busy year for the European Association of Hospital Pharmacists (EAHP). The Association launched its labour mobility survey in January 2018 which showed that 85% of hospital pharmacists and heads of hospital pharmacy who participated in the survey would support the creation of a Common Training Framework (CTF) for the hospital pharmacy specialisation. The results of this survey made it clear that hospital pharmacists are interested in pursuing their free movement rights. Consequently, EAHP continued to push the CTF project forward throughout 2018 and will continue to pursue it in 2019.
Hospital pharmacists from all over the world gathered from 21 to 23 March 2018 in Gothenburg, Sweden, to hear more about the achievements of their profession and to get inspired for future developments. Three keynotes focusing on global health, marketing and the profession itself drew over 3400 hospital pharmacists to the second largest city in Sweden. Workshops, seminars and EAHP's Synergy programme—which featured five Synergy Satellites on biosimilars in cancer and breast cancer care, biologics, anticoagulation and automation—rounded off the 3-day event.
EAHP’s General Assembly in June 2018 marked the start of Petr Horák’s 3-year term in office as new EAHP President. In addition, it saw the adoption of three position papers. A new position paper on procurement advocating for the involvement of hospital pharmacists was agreed on by the delegates. The position on antimicrobial resistance was reviewed to put a stronger emphasis on the contribution by hospital pharmacists to antibiotic stewardship. Also the paper on biosimilar medicines was updated. A technical review allowed for the inclusion of a reference to the Information Guide for Healthcare Professionals on Biosimilars …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned; internally peer reviewed.